Search

OnRamp Bio and NanoString Announce Global Availability of ROSALIND® for nCounter Users

NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, and OnRamp Bioinformatics, a provider of cloud-based genomic analysis tools, today announced a key milestone in their partnership to develop new analysis tools to accelerate research on NanoString’s nCounter® Analysis System. After successful completion of an Early Access Program announced in May, the parties are expanding access to new analysis capabilities to all nCounter users. The new analysis functionality is built into ROSALIND®, OnRamp’s cloud-based analysis platform that facilitates data visualization, exploration and collaboration. NanoString will support ROSALIND as a preferred analysis solution for nCounter data and make it broadly available to users of the nCounter Analysis System.


CONTINUE READING

Recent Posts

See All

Visualizing SoCal’s Diversity Advantage

By: Andy Wilson any of us know that SoCal has a diversity advantage through its breadth of people, industries, and technologies. I like to say that our diversity is our “regional superpower.” Our popu

301 North Lake Avenue, Suite 930, Pasadena, CA 91101       funding@wavemaker360.com

© 2020 Wavemaker Three-Sixty Health